Connection

Nathan Dolloff to Tumor Burden

Back to Details
This is a "connection" page, showing publications Nathan Dolloff has written about Tumor Burden.
Nathan Dolloff
Connection Strength
0.160
Tumor Burden
  1. Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivo. Leuk Res. 2020 01; 88:106271.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.